KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Change in Intangibles (2016 - 2025)

Historic Change in Intangibles for Sarepta Therapeutics (SRPT) over the last 14 years, with Q3 2025 value amounting to $5.3 million.

  • Sarepta Therapeutics' Change in Intangibles changed N/A to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year decrease of 2262.0%. This contributed to the annual value of $10.0 million for FY2024, which is 9019.61% down from last year.
  • According to the latest figures from Q3 2025, Sarepta Therapeutics' Change in Intangibles is $5.3 million.
  • Sarepta Therapeutics' Change in Intangibles' 5-year high stood at $101.9 million during Q2 2023, with a 5-year trough of $94000.0 in Q1 2023.
  • Moreover, its 4-year median value for Change in Intangibles was $1.7 million (2022), whereas its average is $15.1 million.
  • In the last 5 years, Sarepta Therapeutics' Change in Intangibles soared by 1053829.79% in 2024 and then plummeted by 7762.0% in 2025.
  • Over the past 4 years, Sarepta Therapeutics' Change in Intangibles (Quarter) stood at $202000.0 in 2022, then soared by 50348.51% to $101.9 million in 2023, then tumbled by 90.19% to $10.0 million in 2024, then crashed by 46.88% to $5.3 million in 2025.
  • Its Change in Intangibles was $5.3 million in Q3 2025, compared to $188000.0 in Q2 2025 and $2.2 million in Q1 2025.